LEADER 03691nam 2200589 450 001 9910163131103321 005 20170821170235.0 010 $a1-280-67107-6 010 $a9786613648006 010 $a3-8055-9987-0 035 $a(CKB)3240000000066291 035 $a(EBL)3016575 035 $a(SSID)ssj0000629508 035 $a(PQKBManifestationID)11359727 035 $a(PQKBTitleCode)TC0000629508 035 $a(PQKBWorkID)10731167 035 $a(PQKB)11613461 035 $a(MiAaPQ)EBC3016575 035 $a(OCoLC)793598117 035 $a(SZ-BaSKA)256797 035 $a(PPN)175641560 035 $a(EXLCZ)993240000000066291 100 $a20120201d2012 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNew treatments in non-infectious uveitis /$fvolume editors, Elisabetta Miserocchi, Giulio Modorati, C. Stephen Foster 210 1$aBasel :$cKarger,$d[2012] 210 4$dİ2012 215 $a1 online resource (179 p.) 225 1 $aDevelopments in ophthalmology,$x0250-3751 ;$vvolume 51 300 $aDescription based upon print version of record. 311 $a3-8055-9986-2 320 $aIncludes bibliographical references and index. 327 $aThe philosophy of treatment of uveitis : past, present and future / Kruh, J., Foster, C.S. -- The gold standard of noninfectious uveitis : corticosteroids / Lehoang, P. -- Corticosteroid-sparing agents : conventional systemic immunosuppressants / Kruh, J., Foster, C.S. -- Corticosteroid-sparing agents : new treatment options / Tomkins-Netzer, O., Taylor, S.R.J., Lightman, S. -- Mycophenolate mofetil use in the treatment of noninfectious uveitis / Klisovic, D.D. -- Anti-tumor necrosis factor : agents in noninfectious uveitis / Gueudry, J., LeHoang, P., Bodaghi, B. -- New biologic drugs : anti-interleukin therapy -- Tappeiner, C. ... [et al.] -- Interferon / Deuter, C., Stu?biger, N., Zierhut, M. -- Rituximab for the treatment of noninfectious uveitis / Miserocchi, E., Modorati, G. -- Intravitreal injection therapy in the treatment of noninfectious uveitis / Modorati, G., Miserocchi, E. -- Corticosteroid intravitreal implants / de Smet, M.D. -- New treatment options for noninfectious uveitis / Gomes Bittencourt, M. ... [et al.]. 330 $aUveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis. 410 0$aDevelopments in ophthalmology ;$vv. 51. 606 $aUveitis$xGene therapy 615 0$aUveitis$xGene therapy. 676 $a617.7/2 701 $aMiserocchi$b Elisabetta$01208611 701 $aModorati$b Giulio$01208612 701 $aFoster$b C. Stephen$g(Charles Stephen),$f1942-$01013655 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910163131103321 996 $aNew treatments in non-infectious uveitis$92788369 997 $aUNINA